Issue 2/2003
Content (12 Articles)
Modelling of ftorafur and 5-fluorouracil pharmacokinetics following oral UFT administration. A population study in 30 patients with advanced breast cancer
S. Urien, P. Fumoleau, M. Campone, P. Kerbrat, J. Bonneterre, P. Fargeot, R. Deporte-Fety
Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics
Vinicius de Lima Vazquez, O. Anthony Stuart, Faheez Mohamed, Paul H. Sugarbaker
A retrospective evaluation of the feasibility of intrapatient dose escalation as appropriate methodology for dose-ranging studies for combination cytotoxic regimens
Sarah D. Jordan, Christopher J. Poole, Venice R. Archer, Neil M. Steven, Andrea Burton
A phase I trial of weekly paclitaxel, 13-cis-retinoic acid, and interferon alpha in patients with prostate cancer and other advanced malignancies
A. Thalasila, Elizabeth Poplin, J. Shih, Dmitri Dvorzhinski, T. Capanna, S. Doyle-Lindrud, S. Beers, S. Goodin, Eric Rubin, Robert S. DiPaola
Phase II study of biweekly irinotecan and mitomycin C combination therapy in patients with fluoropyrimidine-resistant advanced colorectal cancer
Yasuhide Yamada, Kuniaki Shirao, Ichinosuke Hyodo, Yasuaki Arai, Tadamichi Denda, Tomonori Ambo, Atsushi Ohtsu
Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studies
Daniela Meco, Tina Colombo, Paolo Ubezio, Massimo Zucchetti, Marco Zaffaroni, Anna Riccardi, Glynn Faircloth, Jimeno Jose, Maurizio D'Incalci, Riccardo Riccardi
Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 rats
Steven M. Musser, Merrill J. Egorin, Eleanor G. Zuhowski, Deborah R. Hamburger, Robert A. Parise, Joseph M. Covey, Kevin D. White, Julie L. Eiseman
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study
Michela Donadio, Mara Ardine, Alfredo Berruti, Giuliana Ritorto, Elena Fea, Marinella Mistrangelo, Zaira Coccorullo, Paola Bergnolo, Alessandro Comandone, Oscar Bertetto
Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: a Cancer Therapeutics Research Group study
Ross A. Soo, Hong L. Lim, Ling Z. Wang, How S. Lee, Michael J. Millward, Lay T. Tok, Soo C. Lee, Manfred Lehnert, Boon C. Goh
Analysis of docetaxel pharmacokinetics in humans with the inclusion of later sampling time-points afforded by the use of a sensitive tandem LCMS assay
Daniel L. Gustafson, Michael E. Long, Joseph A. Zirrolli, Mark W. Duncan, Scott N. Holden, A. Scott Pierson, S. Gail Eckhardt
Metabolism of dexrazoxane (ICRF-187) used as a rescue agent in cancer patients treated with high-dose etoposide
Patricia E. Schroeder, Peter Buhl Jensen, Maxwell Sehested, Kenneth Francis Hofland, Seppo W. Langer, Brian B. Hasinoff